Drawing for BLOODRUNNER

USPTO serial 88171078

BLOODRUNNER

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CAPSHAW, DANIEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BLOODRUNNER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Peter Nussbaum

Peter Nussbaum CHIESA SHAHINIAN & GIANTOMASI PCONE BOLAND DRIVEWEST ORANGE, NJ 07052UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Computer game software for personal computers and home video game consoles; downloadable electronic video game programs; computer and video game programsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 21, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 20, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 12, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jan 12, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 12, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 12, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 12, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 17, 2021EX5GSOU EXTENSION 5 GRANTED—
Nov 17, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 10, 2021EXT5SOU EXTENSION 5 FILED—
Nov 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2021EX4GSOU EXTENSION 4 GRANTED—
May 14, 2021EXT4SOU EXTENSION 4 FILED—
May 14, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 28, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2020EX3GSOU EXTENSION 3 GRANTED—
Aug 26, 2020EXT3SOU EXTENSION 3 FILED—
Aug 26, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 14, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 12, 2020EX2GSOU EXTENSION 2 GRANTED—
May 12, 2020EXT2SOU EXTENSION 2 FILED—
May 12, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 29, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 4, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 19, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 17, 2019EX1GSOU EXTENSION 1 GRANTED—
Oct 17, 2019EXT1SOU EXTENSION 1 FILED—
Oct 17, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 14, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 19, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 19, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2019DOCKASSIGNED TO EXAMINER—
Nov 9, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 30, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance